Takasago International Corporation (4914) AI Stock Analysis

• Market Cap: ¥134.93B
• Dividend Yield: 3.77%
• Average Volume (3M): 150.45K
• Price to Earnings (P/E): 14.2
• Beta (1Y): 0.61
• Revenue Growth: 9.07%
• EPS Growth: 152.79%
• Country: JP
• Employees: 4,041
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 13.89
• Shares Outstanding: 100,761,980
• 10 Day Avg. Volume: 159,350
• 30 Day Avg. Volume: 150,450
• PEG Ratio: 0.02
• Price to Book (P/B): 0.86
• Price to Sales (P/S): 0.54
• P/FCF Ratio: 16.26
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 73 Outperform
• Price Target: ¥1,497.00 ▲(1.56% Upside)
• Action: Reiterated Date: 10/29/25
• Date: Action: Reiterated 10/29/25

Takasago International Corporation's overall stock score is driven by strong financial performance and attractive valuation metrics. The company's robust revenue growth and profitability improvements are significant strengths. However, the technical analysis suggests a short-term bearish trend, which slightly offsets the positive financial and valuation aspects. The absence of earnings call and corporate events data means these factors do not influence the score.

Positive Factors

Revenue Growth

The significant revenue growth indicates strong market demand and effective sales strategies, enhancing long-term business sustainability.

R&D Expansion

Investing in R&D infrastructure supports innovation and competitive advantage, crucial for sustained growth in the flavor and fragrance industry.

Leadership Restructuring

Restructuring leadership can enhance strategic direction and operational efficiency, potentially strengthening market position and stakeholder trust.

Negative Factors

Profitability Challenges

Decreasing profitability despite revenue growth suggests cost management issues, which could impact long-term financial health if not addressed.

Exchange Rate Impact

Significant foreign exchange losses highlight vulnerability to currency fluctuations, which can affect financial stability and require strategic hedging.

Export Decline

A decline in exports can signal weakening international competitiveness, potentially limiting growth opportunities in global markets.

Takasago International Corporation Business Overview & Revenue Model

Company Description

Takasago International Corporation manufactures and sells flavors, fragrances, aroma ingredients, and other fine chemicals. The company offers flavors for use in various beverages comprising fruit juices, carbonated drinks, coffee and tea flavored drinks, sports and energy drinks, dairy drinks, alcoholic/ non-alcoholic beverages, powder mixes, protein meal replacement drinks, and others; confectionery products, including candies, chewing gums, compresses mints/tablets, chocolates, cereal/cereal bars, and others; processed meats, seasoning blends and marinades, soups and sauces, bouillons and broths, and surimi and other seafood; breads, donuts and pastries, cookies and crackers, cakes and mixes, pretzels, prep fillings, and others; yogurt, flavored milk, ice cream, frozen desserts, cottage cheese, savor yogurt dips and spreads, fruit preparations, and others; and mint and gums, toothpaste, mouthwash, breath fresheners, medicinal, and other products. It also offers fragrances for use in perfumes and colognes; and various consumer products, such as soaps and shampoos, bath products, cosmetics, laundry detergents, cleansers, air fresheners, and other products, as well as aroma ingredients that are used to create fragrances. In addition, the company provides fine chemicals comprising intermediates of pharmaceuticals and electronics industries. It operates in Japan, the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Takasago International Corporation was founded in 1920 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Takasago International generates revenue primarily through the sale of its flavors and fragrances to a wide range of industries. The company's revenue model is based on long-term contracts and direct sales to manufacturers in food and beverage, cosmetics, and household goods sectors. Key revenue streams include customized flavor solutions for the food and beverage industry, fragrance products for personal care items, and aroma chemicals for industrial applications. Takasago also benefits from partnerships with major global brands, providing tailored solutions that meet specific market demands, which further enhances its revenue potential. Additionally, the company invests in research and development to innovate and improve its product offerings, ensuring a competitive edge in a rapidly evolving market.

Takasago International Corporation Financial Statement Overview

Summary

Takasago International Corporation demonstrates strong financial performance with significant improvements in revenue, profitability, and cash flow metrics. The company's strategic management of costs and revenue growth initiatives have paid off, as reflected in enhanced margins and cash flow. However, past fluctuations in profitability and leverage necessitate careful monitoring to sustain this positive trajectory.

Income Statement

Takasago International Corporation has demonstrated strong revenue growth, with a notable increase in total revenue from 2024 to 2025, marking a growth rate of 16.95%. The gross profit margin improved significantly to 33.77% in 2025 from 28.83% in 2024, indicating efficient cost management. The net profit margin surged to 5.81% from 1.38% in the previous year, showing enhanced profitability. EBIT and EBITDA margins also improved, demonstrating operational efficiency. However, the company showed volatility in profits over the years, which could pose risks.

Balance Sheet

The company's balance sheet reflects a stable financial position with a manageable debt-to-equity ratio of 0.42 in 2025, down from 0.36 in 2024. The equity ratio increased to 54.98% in 2025, indicating a solid equity base. Return on equity improved to 9.24% from 2.09% in 2024, highlighting better equity utilization. Despite the improvements, maintaining the current trajectory is crucial to avoid potential leverage risks.

Cash Flow

Takasago International saw a strong free cash flow growth of 226.82% from 2024 to 2025, indicating improved cash generation capacity. Operating cash flow to net income ratio stood at 1.42 in 2025, demonstrating effective cash conversion. The free cash flow to net income ratio was 0.57, reflecting efficient cash management. While current cash flow metrics are robust, historical volatility suggests the need for vigilance against potential fluctuations.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	231.69B	229.21B	195.94B	186.79B	162.44B	150.37B
Gross Profit	77.79B	77.40B	56.48B	54.44B	51.13B	45.05B
EBITDA	24.90B	26.52B	13.34B	16.40B	15.72B	15.63B
Net Income	12.26B	13.32B	2.70B	7.39B	8.91B	7.15B
Balance Sheet
Total Assets	250.58B	262.17B	228.43B	212.08B	196.84B	184.51B
Cash, Cash Equivalents and Short-Term Investments	13.48B	35.59B	18.33B	14.97B	16.15B	10.88B
Total Debt	53.46B	60.71B	46.73B	44.78B	43.55B	43.70B
Total Liabilities	108.23B	115.78B	97.55B	90.13B	86.55B	83.17B
Stockholders Equity	140.33B	144.20B	129.06B	120.21B	108.61B	99.97B
Cash Flow
Free Cash Flow	0.00	7.62B	2.33B	-589.00M	3.52B	6.78B
Operating Cash Flow	0.00	18.92B	10.01B	5.82B	11.57B	13.73B
Investing Cash Flow	0.00	-9.13B	-6.82B	-3.28B	-7.26B	-4.28B
Financing Cash Flow	0.00	6.88B	-453.00M	-2.04B	-2.36B	-7.86B

Takasago International Corporation Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1474.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4914, the sentiment is Negative. The current price of 1474 is above the 20-day moving average (MA) of 1458.30, below the 50-day MA of 1483.88, and below the 200-day MA of 1482.59, indicating a bearish trend. The MACD of -39.62 indicates Positive momentum. The RSI at 33.34 is Neutral, neither overbought nor oversold. The STOCH value of 13.39 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4914.

Takasago International Corporation Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4187	80 Outperform	¥105.34B	14.05	10.57%	1.74%	15.12%	40.72%
4977	80 Outperform	¥26.58B	6.58	―	1.82%	-7.26%	―
4116	76 Outperform	¥90.26B	12.64	―	3.04%	1.57%	-33.97%
4914	73 Outperform	¥134.93B	14.18	―	3.77%	9.07%	152.79%
4958	70 Outperform	¥119.85B	18.03	5.56%	2.59%	2.58%	-3.16%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
4968	61 Neutral	¥30.20B	18.07	―	4.27%	5.72%	28.92%

Takasago International Corporation Corporate Events

Takasago Books ¥2.543 Billion Extraordinary Gain From Sale of Hisamitsu Shares

Takasago International Corporation has sold all 444,038 shares it held in Hisamitsu Pharmaceutical Co., Inc., including those held via the Hisamitsu Pharmaceutical Shareholding Association, into a tender offer conducted by Taiyo Kosan Co., Inc. The shares were sold at 6,082 yen per share for total proceeds of 2.7 billion yen, with settlement scheduled to begin on February 27, 2026.

The divestment will generate 2.543 billion yen in gain on sale of investment securities, which Takasago will record as extraordinary income in its standalone and consolidated financial statements for the fiscal year ending March 2026. This one-off gain enhances the company’s earnings for the period and has already been incorporated into its revised full-year consolidated earnings forecast disclosed on February 13, 2026.

The most recent analyst rating on (JP:4914) stock is a Buy with a Yen1760.00 price target. To see the full list of analyst forecasts on Takasago International Corporation stock, see the JP:4914 Stock Forecast page.

Takasago Profit Falls on Shipment Delays and ERP Disruptions Despite Stable Core Demand

Takasago International Corporation reported that in the third quarter of FY2025, overseas raw material prices tracked forecasts, but a weaker yen drove higher import costs in Japan, while domestic flavor sales remained stable and beverage flavors and fabric-care fragrances performed solidly in China. However, group net sales fell 4.0% year on year to ¥168.7 billion and operating profit dropped 43.6% to ¥7.4 billion, as shipment delays of pharmaceutical intermediates from the fine chemicals business, reduced volumes in the U.S. subsidiary after clearing a prior backlog, and lower fragrance shipments in France due to ERP-related delivery adjustments weighed on performance, partially offset by improved exchange gains and higher gains on sales of investment securities.

Ordinary profit declined 37.5% to ¥8.8 billion and net income attributable to owners of the parent slipped 36.1% to ¥6.8 billion, even as foreign exchange gains on receivables and payables improved compared with the previous year. Despite the earnings pressure from logistics timing issues and system transitions, the company maintained progress toward its full-year FY2025 targets, with management emphasizing ongoing enhancements to quality management systems in collaboration with major clients, which could support longer-term stability in its pharmaceutical intermediate and broader specialty chemicals operations once shipment timing normalizes.

The most recent analyst rating on (JP:4914) stock is a Buy with a Yen1760.00 price target. To see the full list of analyst forecasts on Takasago International Corporation stock, see the JP:4914 Stock Forecast page.

Takasago Cuts FY2025 Earnings Outlook on Weak Americas and Fine Chemicals Slump

Takasago International Corporation has lowered its consolidated forecast for the fiscal year ending March 31, 2026, cutting projected net sales from ¥230.0 billion to ¥225.0 billion and operating income from ¥12.5 billion to ¥8.5 billion, with net income attributable to owners of the parent reduced to ¥10.5 billion. The revision reflects weaker-than-expected sales in the Americas and Europe, delays in U.S. pharmaceutical intermediates shipments under stricter quality controls, and reduced exports of pharmaceutical intermediates from Japan, partly offset by solid flavor and fragrance demand in Japan, China and Southeast Asia and an expected ¥2.4 billion gain on sales of investment securities that will cushion the decline in profits.

Regionally, sales and profit forecasts were trimmed most sharply in the Americas, where fragrance shipments fell and operating profit is now expected to drop to ¥0.8 billion, while Japan’s operating profit outlook was also cut despite slightly higher sales. By business line, the fine chemicals segment saw the largest downgrade, with net sales guidance slashed from ¥14.4 billion to ¥8.3 billion and operating profit projected to swing from a ¥2.2 billion profit to a ¥0.5 billion loss, highlighting operational and demand challenges in that area even as the core flavors and fragrances businesses hold relatively steady.

The most recent analyst rating on (JP:4914) stock is a Buy with a Yen1760.00 price target. To see the full list of analyst forecasts on Takasago International Corporation stock, see the JP:4914 Stock Forecast page.

Takasago Profit Slumps Despite Higher Dividend After Stock Split

Takasago International reported consolidated net sales of ¥168.7 billion for the nine months ended December 31, 2025, down 4.0% year on year, with operating profit plunging 43.6% to ¥7.4 billion and profit attributable to owners of parent falling 36.1% to ¥6.8 billion. Despite slightly higher total assets and net assets, profitability contracted sharply versus the strong rebound a year earlier, as reflected in lower basic earnings per share.

The company revised its dividend outlook in light of a five-for-one stock split effective October 1, 2025, paying an interim dividend of ¥120 per share on a pre-split basis and forecasting a year-end dividend of ¥28 per share post-split. On an equivalent basis, the implied full-year dividend would be ¥260 per share, signaling a modest increase in shareholder returns even as earnings soften, which may reassure investors about management’s commitment to capital policy stability.

The most recent analyst rating on (JP:4914) stock is a Buy with a Yen1760.00 price target. To see the full list of analyst forecasts on Takasago International Corporation stock, see the JP:4914 Stock Forecast page.

Takasago to Unwind Hisamitsu Stake, Booking ¥2.4 Billion Extraordinary Gain

Takasago International Corporation’s board has resolved to accept a tender offer from Taiyo Kosan Co., Inc. for all 420,534 shares of Hisamitsu Pharmaceutical Co., Inc. that it holds as cross-shareholdings, at a price of ¥6,082 per share for total planned proceeds of about ¥2.56 billion. The divestment, which follows Hisamitsu’s own board approval of the offer terms, is expected to generate approximately ¥2.41 billion in extraordinary income as a gain on sales of investment securities in Takasago’s fiscal year ending March 31, 2026, potentially strengthening its balance sheet and giving the company more financial flexibility, while also aligning with ongoing market pressure in Japan to unwind cross-shareholdings.

The most recent analyst rating on (JP:4914) stock is a Buy with a Yen1760.00 price target. To see the full list of analyst forecasts on Takasago International Corporation stock, see the JP:4914 Stock Forecast page.